These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1542302

  • 1. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent.
    Yamauchi A, Masutani H, Tagaya Y, Wakasugi N, Mitsui A, Nakamura H, Inamoto T, Ozawa K, Yodoi J.
    Mol Immunol; 1992 Feb; 29(2):263-70. PubMed ID: 1542302
    [Abstract] [Full Text] [Related]

  • 2. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state.
    Iwata S, Hori T, Sato N, Hirota K, Sasada T, Mitsui A, Hirakawa T, Yodoi J.
    J Immunol; 1997 Apr 01; 158(7):3108-17. PubMed ID: 9120263
    [Abstract] [Full Text] [Related]

  • 3. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T.
    Proc Natl Acad Sci U S A; 1990 Nov 01; 87(21):8282-6. PubMed ID: 2172979
    [Abstract] [Full Text] [Related]

  • 4. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
    Iwata S, Hori T, Sato N, Ueda-Taniguchi Y, Yamabe T, Nakamura H, Masutani H, Yodoi J.
    J Immunol; 1994 Jun 15; 152(12):5633-42. PubMed ID: 8207197
    [Abstract] [Full Text] [Related]

  • 5. IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.
    Yodoi J, Tagaya Y, Masutani H, Maeda Y, Kawabe T.
    Princess Takamatsu Symp; 1988 Jun 15; 19():73-86. PubMed ID: 2978620
    [Abstract] [Full Text] [Related]

  • 6. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction.
    Tagaya Y, Wakasugi H, Masutani H, Nakamura H, Iwata S, Mitsui A, Fujii S, Wakasugi N, Tursz T, Yodoi J.
    Mol Immunol; 1990 Dec 15; 27(12):1279-89. PubMed ID: 2177148
    [Abstract] [Full Text] [Related]

  • 7. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
    Yamauchi A, Bloom ET.
    J Immunol; 1993 Nov 15; 151(10):5535-44. PubMed ID: 8228244
    [Abstract] [Full Text] [Related]

  • 8. ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approach.
    Masutani H, Nakamura H, Ueda Y, Kitaoka Y, Kawabe T, Iwata S, Mitsui A, Yodoi J.
    Adv Exp Med Biol; 1992 Nov 15; 319():265-74. PubMed ID: 1329444
    [Abstract] [Full Text] [Related]

  • 9. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).
    Blum H, Röllinghoff M, Gessner A.
    Cytokine; 1996 Jan 15; 8(1):6-13. PubMed ID: 8742061
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX).
    Hori K, Katayama M, Sato N, Ishii K, Waga S, Yodoi J.
    Brain Res; 1994 Aug 01; 652(2):304-10. PubMed ID: 7953744
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
    U-Taniguchi Y, Furuke K, Masutani H, Nakamura H, Yodoi J.
    Oncol Res; 1995 Aug 01; 7(3-4):183-9. PubMed ID: 8555652
    [Abstract] [Full Text] [Related]

  • 12. Activation of murine lymphocytes by 2-mercapto-ethanol and related thiol compounds and its mechanism. II. Effect of thiol compounds on the viability of the lymphocytes under a cystine-deficient culture condition.
    Ohmori H, Yamauchi T, Yamamoto I.
    J Pharmacobiodyn; 1986 Jul 01; 9(7):607-12. PubMed ID: 3772717
    [Abstract] [Full Text] [Related]

  • 13. Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.
    Makino S, Masutani H, Maekawa N, Konishi I, Fujii S, Yamamoto R, Yodoi J.
    Immunology; 1992 Aug 01; 76(4):578-83. PubMed ID: 1398748
    [Abstract] [Full Text] [Related]

  • 14. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
    Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H.
    EMBO J; 1989 Mar 01; 8(3):757-64. PubMed ID: 2785919
    [Abstract] [Full Text] [Related]

  • 15. Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients.
    Masutani H, Naito M, Takahashi K, Hattori T, Koito A, Takatsuki K, Go T, Nakamura H, Fujii S, Yoshida Y.
    AIDS Res Hum Retroviruses; 1992 Sep 01; 8(9):1707-15. PubMed ID: 1457216
    [Abstract] [Full Text] [Related]

  • 16. [Measurement of ADF/thioredoxin in human serum and its clinical significance].
    Kitaoka Y, Sachi Y, Mori T, Yodoi J.
    Rinsho Byori; 1994 Aug 01; 42(8):853-9. PubMed ID: 7933622
    [Abstract] [Full Text] [Related]

  • 17. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells.
    Matsuda M, Masutani H, Nakamura H, Miyajima S, Yamauchi A, Yonehara S, Uchida A, Irimajiri K, Horiuchi A, Yodoi J.
    J Immunol; 1991 Dec 01; 147(11):3837-41. PubMed ID: 1719091
    [Abstract] [Full Text] [Related]

  • 18. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
    Furuke K, Nakamura H, Hori T, Iwata S, Maekawa N, Inamoto T, Yamaoka Y, Yodoi J.
    Int Immunol; 1995 Jun 01; 7(6):985-93. PubMed ID: 7577807
    [Abstract] [Full Text] [Related]

  • 19. Detection of adult T-cell leukemia-derived factor/human thioredoxin in human serum.
    Kitaoka Y, Sorachi K, Nakamura H, Masutani H, Mitsui A, Kobayashi F, Mori T, Yodoi J.
    Immunol Lett; 1994 Jul 01; 41(2-3):155-61. PubMed ID: 8002031
    [Abstract] [Full Text] [Related]

  • 20. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
    Sono H, Teshigawara K, Sasada T, Takagi Y, Nishiyama A, Ohkubo Y, Maeda Y, Tatsumi E, Kanamaru A, Yodoi J.
    Antioxid Redox Signal; 1999 Jul 01; 1(2):155-65. PubMed ID: 11228744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.